RedBrick AI vs Figma
Side-by-side comparison of AI visibility scores, market position, and capabilities
Medical imaging annotation platform accelerating AI training data creation by 60%; $5.1M from Peak XV and YC serving hospitals and healthcare AI companies for FDA-cleared model development.
About
RedBrick AI is a healthcare AI platform specializing in medical imaging annotation — providing the configurable workflow system, annotation tools, and quality management features that hospitals, research institutions, and healthcare AI companies need to create high-quality training datasets for medical AI models. Founded in 2021 and backed by Peak XV Partners (formerly Sequoia Capital India) and Y Combinator with $5.1 million raised, RedBrick AI serves customers training AI models on CT scans, MRI, X-rays, and ultrasound images, accelerating annotation workflows by up to 60%.\n\nRedBrick AI's platform provides specialized annotation tools for 3D medical imaging (segmentation brushes for 3D volumes, DICOM viewer integration, measurement tools), configurable review workflows (managing the multi-step annotation, verification, and adjudication process required for medical-grade data quality), and active learning integration (prioritizing the most informative cases for human annotation to maximize model improvement per annotation hour). The platform handles the regulatory documentation requirements for medical AI development, including audit trails that support FDA submission.\n\nIn 2025, RedBrick AI competes in the medical AI training data and annotation market with Scale AI (general-purpose data annotation), Appen, CVAT (open-source), and specialized medical annotation platforms like MD.ai for medical image annotation tools. The healthcare AI market is growing rapidly as FDA-cleared AI diagnostic tools proliferate — each new radiology AI model requires thousands of annotated images for training, and the quality of annotations directly affects model safety. RedBrick AI's medical-specific tooling (3D annotation, DICOM handling, clinical workflow) provides depth that general annotation platforms lack. The 2025 strategy focuses on growing with hospital systems building internal AI capabilities, deepening regulatory compliance documentation, and expanding from imaging to other medical data modalities (pathology slides, clinical notes).
Dominant browser-based collaborative UI design platform at ~$600M ARR and $12.5B valuation; Adobe's $20B acquisition blocked by regulators in 2023, Figma remains independent competing with Sketch and Adobe.
About
Figma is a San Francisco-based collaborative web-based product design platform that has become the dominant tool for UI/UX designers and product teams — enabling real-time multi-user collaboration on interface design, prototyping, and design system management directly in the browser without installing desktop software. Founded in 2012 by Dylan Field and Evan Wallace and backed by Sequoia, Greylock, and Andreessen Horowitz with over $330 million raised, Figma generated approximately $600 million in ARR in 2023, serving 4 million+ designers and product teams at companies including Microsoft, Airbnb, Twitter, and Uber. Adobe announced a $20 billion acquisition offer in 2022, which was blocked by regulators in 2023 — Figma remains independent.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.